Status:
WITHDRAWN
Study of Value of Dexamethasone Used in Ovulation Induction
Lead Sponsor:
Reproductive & Genetic Hospital of CITIC-Xiangya
Conditions:
Infertility, Female
Eligibility:
FEMALE
18-35 years
Phase:
NA
Brief Summary
This study intends to solve the following problems: whether use dexamethasone can obviously decrease transplant cancelling probability in fresh embryo transplant cycle or not, reduce time and frequenc...
Eligibility Criteria
Inclusion
- \- female, 18 years old≤age≤35 years old, 18≤BMI≤25, standard patient, menstrual regularity
Exclusion
- Hyperprolactinemia, Thyroid dysfunction, uterine malformation ( inadequacy mediastinal uterus ≥1.0cm, Unicornate uterus, double uterus, T Angle of uterus, etc.), uterus adhesion, untreated hydrosalpinx , hysteromyoma（ hysteromyoma≥1.0 cm, and/or endometrial hysteromyoma≤1 cm), endometriosis, diabetes, hypertension, adrenal cortex hyperplasia, Cushing's syndrome, a pituitary amenorrhea
Key Trial Info
Start Date :
April 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 30 2021
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03421041
Start Date
April 1 2018
End Date
March 30 2021
Last Update
January 11 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Reproductive & Genetic Hospital of CITIC-XIANGYA
Changsha, Hunan, China, 410000